RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 137 filers reported holding RIGEL PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 3.20 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $622,000 | +59.1% | 177,810 | -16.9% | 0.49% | +156.8% |
| Q2 2020 | $391,000 | -24.8% | 214,040 | -35.8% | 0.19% | -40.0% |
| Q1 2020 | $520,000 | +1825.9% | 333,389 | +2532.6% | 0.32% | +2361.5% |
| Q4 2019 | $27,000 | -94.2% | 12,664 | -94.9% | 0.01% | -95.1% |
| Q3 2019 | $469,000 | -21.2% | 250,693 | +10.0% | 0.27% | -18.8% |
| Q2 2019 | $595,000 | +28.5% | 227,943 | +4.0% | 0.33% | +27.5% |
| Q1 2019 | $463,000 | +131.5% | 219,143 | +150.7% | 0.26% | +70.9% |
| Q4 2018 | $200,000 | +525.0% | 87,400 | +774.0% | 0.15% | +529.2% |
| Q3 2018 | $32,000 | – | 10,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tamarack Advisers, LP | 8,350,000 | $28,557,000 | 5.86% |
| Ion Asset Management Ltd. | 3,632,132 | $12,422,000 | 1.43% |
| CM Management, LLC | 500,000 | $1,710,000 | 1.27% |
| SECTOR GAMMA AS | 1,530,490 | $5,234,000 | 0.96% |
| Rhenman & Partners Asset Management AB | 1,520,000 | $5,198,000 | 0.36% |
| Rock Springs Capital Management LP | 4,742,000 | $16,218,000 | 0.35% |
| Telemetry Investments, L.L.C. | 90,000 | $308,000 | 0.35% |
| DAFNA Capital Management LLC | 275,500 | $942,000 | 0.22% |
| KELLEHER FINANCIAL ADVISORS | 100,000 | $342,000 | 0.22% |
| Virtus ETF Advisers LLC | 91,971 | $315,000 | 0.13% |